To evaluate the clinical significance of two immunonutritional biomarkers, the HALP (hemoglobin, albumin, lymphocyte, and platelet) score and the CALLY (C-reactive protein, albumin, and lymphocyte) index, in patients with sudden sensorineural hearing loss (SSNHL) and to explore their association with hearing recovery.
✦ The floor
Discussion
Signed responses from readers of the wire.
The HALP score and CALLY index show potential as prognostic markers in sudden sensorineural hearing loss, but evidence is currently insufficient to recommend routine clinical use; further prospective validation is needed.
Identifying reliable, low-cost biomarkers for sudden sensorineural hearing loss could improve risk stratification and guide treatment decisions in a condition with unpredictable outcomes.
- 01HALP score and CALLY index are immunonutritional markers derived from routine blood tests.
- 02Both markers were evaluated as clinical indicators in sudden sensorineural hearing loss patients.
- 03Immunonutritional status may play a role in sudden hearing loss prognosis.
- 04Results are exploratory and require prospective validation before clinical adoption.
- 05If validated, these markers could offer a low-cost prognostic tool in emergency ENT settings.
The HALP score and CALLY index can serve as clinical indicators in patients with sudden sensorineural hearing loss.
studypartially supportedImmunonutritional status is associated with outcomes in sudden sensorineural hearing loss.
studyunclear- PMID
- 43000552
- DOI
- 10.1007/s00405-026-10803-x.
- Journal
- European Archives of Oto-Rhino-Laryngology
- Publication type
- research_article
- Evidence level
- 4
- Population
- Patients with sudden sensorineural hearing loss
- Intervention
- Evaluation of HALP score and CALLY index as immunonutritional biomarkers
Primary outcomes
Utility of HALP score as a clinical indicator in sudden sensorineural hearing loss; Utility of CALLY index as a clinical indicator in sudden sensorineural hearing loss